153.10
price up icon2.03%   3.04
after-market アフターアワーズ: 153.70 0.60 +0.39%
loading
前日終値:
$150.06
開ける:
$149.23
24時間の取引高:
1.25M
Relative Volume:
0.70
時価総額:
$9.60B
収益:
$409.48M
当期純損益:
$-81.28M
株価収益率:
-115.23
EPS:
-1.3286
ネットキャッシュフロー:
$-95.14M
1週間 パフォーマンス:
+12.30%
1か月 パフォーマンス:
+76.91%
6か月 パフォーマンス:
+226.30%
1年 パフォーマンス:
+463.07%
1日の値動き範囲:
Value
$148.44
$155.44
1週間の範囲:
Value
$135.05
$155.44
52週間の値動き範囲:
Value
$23.30
$155.44

Twist Bioscience Corp Stock (TWST) Company Profile

Name
名前
Twist Bioscience Corp
Name
セクター
Healthcare (1082)
Name
電話
800-719-0671
Name
住所
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Name
職員
979
Name
次回の収益日
2026-08-03
Name
最新のSEC提出書
Name
TWST's Discussions on Twitter

Compare TWST vs TMO, DHR, NTRA, A, IQV

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
TWST icon
TWST
Twist Bioscience Corp
153.10 8.55B 409.48M -81.28M -95.14M -1.3286
TMO icon
TMO
Thermo Fisher Scientific Inc
630.70 232.03B 45.20B 6.87B 6.75B 18.19
DHR icon
DHR
Danaher Corp
215.68 151.78B 24.78B 3.68B 5.29B 5.1743
NTRA icon
NTRA
Natera Inc
338.70 46.82B 2.50B -226.32M 71.51M -1.6412
A icon
A
Agilent Technologies Inc
157.69 44.14B 7.23B 1.41B 1.09B 4.979
IQV icon
IQV
Iqvia Holdings Inc
262.38 42.15B 16.63B 1.39B 2.12B 8.0674

Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-11-04 開始されました Stephens Overweight
2024-12-13 開始されました Wolfe Research Outperform
2024-06-04 開始されました Guggenheim Buy
2024-01-17 アップグレード Goldman Neutral → Buy
2023-09-27 開始されました Berenberg Buy
2023-01-05 開始されました Scotiabank Sector Outperform
2023-01-03 アップグレード Evercore ISI In-line → Outperform
2022-03-02 再開されました Cowen Outperform
2021-10-15 再開されました Cowen Outperform
2021-06-29 開始されました William Blair Outperform
2021-06-04 開始されました Goldman Neutral
2021-04-12 開始されました Piper Sandler Overweight
2021-02-05 ダウングレード JP Morgan Neutral → Underweight
2021-01-04 ダウングレード Evercore ISI Outperform → In-line
2020-10-20 開始されました SVB Leerink Mkt Perform
2019-05-31 開始されました Evercore ISI Outperform
2018-11-26 開始されました JP Morgan Neutral
すべてを表示

Twist Bioscience Corp (TWST) 最新ニュース

pulisher
Aug 21, 2026

Twist Bioscience Executive Dennis Cho Sells 14,205 Shares Under 10b5-1 Plan in August 2026 - Kalkine Media

Aug 21, 2026
pulisher
Aug 21, 2026

Twist Bioscience Stock Surges As Anthropic AI Deal And Upbeat Guidance Reset Outlook - StocksToTrade

Aug 21, 2026
pulisher
Aug 21, 2026

Twist Bioscience (NASDAQ: TWST) seller plans more after $14.2M August stock trade - Stock Titan

Aug 21, 2026
pulisher
Aug 21, 2026

Twist Bioscience (NASDAQ: TWST) officer adds $189K sale after $2.1M June trade - Stock Titan

Aug 21, 2026
pulisher
Aug 21, 2026

Twist Bioscience (NASDAQ: TWST) holder to sell 1,965 shares for taxes, compensation - Stock Titan

Aug 21, 2026
pulisher
Aug 21, 2026

Twist Bioscience (NASDAQ: TWST) officer booked $1.84M in one sale, now plans more stock trades - Stock Titan

Aug 21, 2026
pulisher
Aug 21, 2026

Twist Bioscience (NASDAQ: TWST) insider to sell 669 shares - Stock Titan

Aug 21, 2026
pulisher
Aug 21, 2026

Twist Bioscience (NASDAQ: TWST) officer to sell 4,046 shares after $9.2M August sale - Stock Titan

Aug 21, 2026
pulisher
Aug 20, 2026

Twist Bioscience Corp (TWST) Stock Down 4.3% but Still Overvalued -- GF Score: 69/100 - GuruFocus

Aug 20, 2026
pulisher
Aug 20, 2026

Twist Bioscience (TWST) COO sells 78K shares under 10b5-1 plan - Stock Titan

Aug 20, 2026
pulisher
Aug 20, 2026

Twist Bioscience stock hits 52-week high at 143.1 USD - Investing.com

Aug 20, 2026
pulisher
Aug 20, 2026

Twist Bioscience (NASDAQ:TWST) Shares Gap DownHere's What Happened - MarketBeat

Aug 20, 2026
pulisher
Aug 20, 2026

Twist Bioscience stock hits 52-week high at 143.1 USD By Investing.com - Investing.com Canada

Aug 20, 2026
pulisher
Aug 20, 2026

Twist Bioscience benefits from Claude's advances in protein design - marketscreener.com

Aug 20, 2026
pulisher
Aug 19, 2026

Twist Bioscience Registers 35,114 Shares for Resale by Invenra - Minichart

Aug 19, 2026
pulisher
Aug 19, 2026

Twist Bioscience files prospectus supplement for Invenra share resale - Investing.com

Aug 19, 2026
pulisher
Aug 19, 2026

Twist Bioscience (NASDAQ: TWST) clears path for 35K-share resale - Stock Titan

Aug 19, 2026
pulisher
Aug 19, 2026

Twist Bioscience Stock Rallies As Guidance And Targets Jump - StocksToTrade

Aug 19, 2026
pulisher
Aug 19, 2026

Twist Bioscience Stock Resilient Despite Scorpion Capital Short Report - Benzinga

Aug 19, 2026
pulisher
Aug 19, 2026

Short seller Scorpion Capital bets against Twist Biosciences questioning AI partnership claims - Investing.com

Aug 19, 2026
pulisher
Aug 19, 2026

Twist Bioscience Shares Rise After Selection by Anthropic to Evaluate Protein Design Project - marketscreener.com

Aug 19, 2026
pulisher
Aug 19, 2026

Twist Bioscience (NASDAQ: TWST) officer may sell $1.84M in shares - Stock Titan

Aug 19, 2026
pulisher
Aug 19, 2026

Twist Bioscience jumps as investors build on strong guidance and AI-drug-discovery enthusiasm - Quiver Quantitative

Aug 19, 2026
pulisher
Aug 19, 2026

TWST Looks 163.5% Overvalued on GF Value™ - GuruFocus

Aug 19, 2026
pulisher
Aug 19, 2026

Twist Bioscience Up Over 17%, on Track for Highest Close Since April 2021 -- Data Talk - Bitget

Aug 19, 2026
pulisher
Aug 19, 2026

Twist Bioscience (NASDAQ:TWST) Hits New 52-Week HighShould You Buy? - MarketBeat

Aug 19, 2026
pulisher
Aug 19, 2026

Why is Twist Bioscience stock surging today? - Investing.com

Aug 19, 2026
pulisher
Aug 19, 2026

Why is Twist Bioscience stock surging today? By Investing.com - Investing.com Canada

Aug 19, 2026
pulisher
Aug 19, 2026

Twist Bioscience Selected as Independent Evaluator in Anthropic's AI-Driven Protein Design Initiative - Kalkine Media

Aug 19, 2026
pulisher
Aug 19, 2026

Form 8K Twist Bioscience Corp For: 19 August By Investing.com - Investing.com Nigeria

Aug 19, 2026
pulisher
Aug 19, 2026

Twist Bioscience selected as evaluator for Anthropic AI protein design project - Investing.com

Aug 19, 2026
pulisher
Aug 19, 2026

Anthropic selects Twist Bioscience as independent evaluator for AI-designed protein testing - TradingView

Aug 19, 2026
pulisher
Aug 18, 2026

Twist Bioscience (NASDAQ: TWST) insider plans multimillion-dollar stock sale - Stock Titan

Aug 18, 2026
pulisher
Aug 17, 2026

A Look at Twist Bioscience Corp (TWST) After 5.0% Gain -- GF Val - GuruFocus

Aug 17, 2026
pulisher
Aug 17, 2026

Twist Bioscience (TWST) Is Down 5.1% After Upsized Equity Raise And Guidance Hike Has The Bull Case Changed? - simplywall.st

Aug 17, 2026
pulisher
Aug 17, 2026

Bank of America Corp DE Grows Stake in Twist Bioscience Corporation $TWST - MarketBeat

Aug 17, 2026
pulisher
Aug 14, 2026

Twist Bioscience CEO Emily Leproust Executes Sale of 19,952 Shares via 10b5-1 Plan - Kalkine Media

Aug 14, 2026
pulisher
Aug 14, 2026

Twist Bioscience Corp (TWST) Stock Down 5.4% but Still Overvalued -- GF Score: 69/100 - GuruFocus

Aug 14, 2026
pulisher
Aug 14, 2026

Twist Bioscience Director Katryn Blake Executes Sell-to-Cover of 2,240 Shares for RSU Tax Obligations - Kalkine Media

Aug 14, 2026
pulisher
Aug 14, 2026

Twist Bioscience (TWST) director sells 2,240 shares to cover RSU tax - Stock Titan

Aug 14, 2026
pulisher
Aug 14, 2026

Twist Bioscience (TWST): ARK Investment Management reports 4.55M-share, 7.31% stake - Stock Titan

Aug 14, 2026
pulisher
Aug 14, 2026

Twist Bioscience (NASDAQ:TWST) Trading Down 4.3%Here's What Happened - MarketBeat

Aug 14, 2026
pulisher
Aug 14, 2026

symbol__ Stock Quote Price and Forecast - CNN

Aug 14, 2026
pulisher
Aug 14, 2026

T. Rowe Price Associates (TWST) discloses 3.63M-share Twist Bioscience position - Stock Titan

Aug 14, 2026
pulisher
Aug 14, 2026

Twist Bioscience (TWST): EdgePoint discloses 4.21% beneficial stake in amended 13G - Stock Titan

Aug 14, 2026
pulisher
Aug 13, 2026

Artisan Partners group (TWST) discloses 4.8M-share position in Twist Bioscience - Stock Titan

Aug 13, 2026
pulisher
Aug 13, 2026

Twist Bioscience stock hits 52-week high at 126.22 USD By Investing.com - Investing.com Australia

Aug 13, 2026
pulisher
Aug 13, 2026

Twist Bioscience stock hits 52-week high at 126.22 USD - Investing.com

Aug 13, 2026
pulisher
Aug 12, 2026

Twist Bioscience CEO Emily Leproust Executes Stock Option Exercise and Sells 113,318 Shares Under 10b5-1 Plan - Kalkine Media

Aug 12, 2026
pulisher
Aug 12, 2026

Insider Selling: Twist Bioscience (NASDAQ:TWST) CEO Sells $14,182,880.88 in Stock - MarketBeat

Aug 12, 2026
pulisher
Aug 12, 2026

Twist Bioscience (TWST) insider Leproust plans resale after option exercise - Stock Titan

Aug 12, 2026

Twist Bioscience Corp (TWST) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
LH LH
$336.54
price up icon 0.24%
MTD MTD
$1,407.43
price up icon 0.64%
$227.69
price up icon 1.27%
WAT WAT
$421.26
price up icon 1.71%
$545.08
price down icon 1.51%
IQV IQV
$262.38
price up icon 0.33%
大文字化:     |  ボリューム (24 時間):